UK markets close in 20 minutes

ARCH THERAPEUTICS INC ARCH THER (0HHJ.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.8000+0.7294 (+1,033.14%)
As of 05:36PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 3.56
52-week change 30.00%
S&P500 52-week change 321.08%
52-week high 30.8000
52-week low 30.0000
50-day moving average 30.8000
200-day moving average 30.8000

Share statistics

Avg vol (3-month) 31
Avg vol (10-day) 31
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.81M
% held by insiders 125.13%
% held by institutions 125.30%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,258.70%

Management effectiveness

Return on assets (ttm)-185.96%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)115.33k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)632.60%
Gross profit (ttm)N/A
EBITDA -5.26M
Net income avi to common (ttm)-7.86M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)205.85k
Total cash per share (mrq)0.04
Total debt (mrq)7.14M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.16
Book value per share (mrq)-2.02

Cash flow statement

Operating cash flow (ttm)-3.59M
Levered free cash flow (ttm)-1.96M